シンガポール政府が重大発表。新型コロナウイルスの感染コントロールのターニングポイントになった可能性が高い。人類の勝利は近い。
紹介した商品
山中伸弥教授紹介のBuff (バフ)の詳細はこちらのリンクから：
DNAパパが動画で以前紹介したマスク 新型コロナ感染予防グッズ：
動画で使用したスライド
参考文献と出典
Subgenomic mRNA
https://en.wikipedia.org/wiki/Subgenomic_mRNA
Question: A Polymerase Chain Reaction (PCR) Is A Laboratory Method To
https://www.chegg.com/homework-help/questions-and-answers/polymerase-chain-reaction-pcr-laboratory-method-amplify-targeted-fragments-dna-molecule-qu-q16677375
Prevalence of Asymptomatic SARS-CoV-2 Infection
https://www.acpjournals.org/doi/10.7326/M20-3012#.XtjqMSXujHA.twitter
Projecting the transmission dynamics of SARS-CoV-2 through the postpandemic period
https://science.sciencemag.org/content/368/6493/860
コロナ感染者“新基準” 陰性確認不要で退院へ【佐賀県】
https://www.sagatv.co.jp/news/archives/2020060102828
Position Statement from the National Centre for Infectious Diseases and the Chapter of Infectious Disease Physicians, Academy of Medicine, Singapore – 23 May 2020
https://www.ams.edu.sg/view-pdf.aspx?file=media%5C5556_fi_331.pdf&ofile=Period+of+Infectivity+Position+Statement+(final)+23-5-20+(logos).pdf
新型コロナウィルス抗体 第二回東京の500例測定結果について
https://www.rcast.u-tokyo.ac.jp/ja/news/report/20200604.html
REVISED DISCHARGE CRITERIA FOR COVID-19 PATIENTS
https://www.moh.gov.sg/news-highlights/details/revised-discharge-criteria-for-covid-19-patients
New study finds COVID-19 patients remain infectious for only this number of days
https://www.theladders.com/career-advice/new-study-finds-covid-19-patients-remain-infectious-for-only-this-number-of-days
A woman says she’s had 8 positive coronavirus tests in 50 days. How long can it really take to recover?
https://www.cbsnews.com/news/coronavirus-symptoms-8-positive-tests-50-days/
北九州の陽性者、無症状が5割超 PCR検査対象拡充で顕在化
https://www.nishinippon.co.jp/item/n/613286/
中国･武漢市、新型コロナ無症状感染300人確認 全市民対象の検査で
https://www.newsweekjapan.jp/stories/world/2020/06/300-10.php
アングル：無症状者に感染力はないのか、中国発表に残る疑念
https://jp.reuters.com/article/health-coronavirus-asymptomatic-idJPKBN23B3GC
Nextstrain
https://nextstrain.org/
Spike mutation pipeline reveals the emergence of a more transmissible form of SARS-CoV-2
https://www.biorxiv.org/content/10.1101/2020.04.29.069054v1.full
岩井化学薬品
新型コロナウイルスSARS-CoV-2 (2019-nCoV) 研究用試薬
https://www.iwai-chem.co.jp/products/sinobiological/sars-cov-2/
Phylogenetic network analysis of SARS-CoV-2 genomes
https://www.pnas.org/content/early/2020/04/07/2004999117
GISAID
https://www.gisaid.org/
GISAID 系統樹
https://www.gisaid.org/epiflu-applications/next-hcov-19-app/
YouTube動画：
DNAパパのツイッター:
コメント